This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Nathalie Rioux: Innovator in Breast Cancer Treatment
Introduction
Nathalie Rioux is a prominent inventor based in Woburn, MA (US). She has made significant contributions to the field of cancer treatment, particularly in developing innovative therapies for breast cancer. Her work is characterized by a commitment to improving patient outcomes through scientific research and development.
Latest Patents
Nathalie holds 1 patent for her groundbreaking work titled "Combination therapies for the treatment of breast cancer." This patent describes a combination therapy that includes an ER-alpha inhibitor and a CDK 4/6 inhibitor, providing a novel approach to treating breast cancer effectively.
Career Highlights
Nathalie Rioux is currently employed at Eisai R&D Management Co., Ltd., where she continues to advance her research in oncology. Her dedication to innovation in cancer therapies has positioned her as a key figure in the pharmaceutical industry.
Collaborations
Throughout her career, Nathalie has collaborated with esteemed colleagues, including Craig D. Karr and Manav Korpal. These partnerships have fostered a collaborative environment that enhances the development of effective cancer treatments.
Conclusion
Nathalie Rioux's contributions to breast cancer treatment through her innovative patent and collaborative efforts highlight her importance in the field of medical research. Her work continues to inspire advancements in cancer therapies that can significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile